» Articles » PMID: 35205422

Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome

Abstract

Polycystic ovary syndrome (PCOS) is a very common endocrine condition in women in India. Gut microbiome alterations were shown to be involved in PCOS, yet it is remarkably understudied in Indian women who have a higher incidence of PCOS as compared to other ethnic populations. During the regional PCOS screening program among young women, we recruited 19 drug naive women with PCOS and 20 control women at the Sher-i-Kashmir Institute of Medical Sciences, Kashmir, North India. We profiled the gut microbiome in faecal samples by 16S rRNA sequencing and included 40/58 operational taxonomic units (OTUs) detected in at least 1/3 of the subjects with relative abundance (RA) ≥ 0.1%. We compared the RAs at a family/genus level in PCOS/non-PCOS groups and their correlation with 33 metabolic and hormonal factors, and corrected for multiple testing, while taking the variation in day of menstrual cycle at sample collection, age and BMI into account. Five genera were significantly enriched in PCOS cases: , , and previously reported for PCOS , and confirmed by different statistical models. At the family level, the relative abundance of was enriched, whereas was decreased among cases. We observed increased relative abundance of and with higher fasting blood glucose levels, and and with larger hip, waist circumference, weight, and with lower prolactin levels. We also detected a novel association between and follicle-stimulating hormone levels and between and alkaline phosphatase, independently of the BMI of the participants. Our report supports that there is a relationship between gut microbiome composition and PCOS with links to specific reproductive health metabolic and hormonal predictors in Indian women.

Citing Articles

Influence of gender, age, and body mass index on the gut microbiota of individuals from South China.

Li S, Fan S, Ma Y, Xia C, Yan Q Front Cell Infect Microbiol. 2024; 14:1419884.

PMID: 39544283 PMC: 11560914. DOI: 10.3389/fcimb.2024.1419884.


Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review.

Wydra J, Szlendak-Sauer K, Zgliczynska M, Zeber-Lubecka N, Ciebiera M Nutrients. 2024; 16(19).

PMID: 39408349 PMC: 11478613. DOI: 10.3390/nu16193382.


The Novel Insight of Gut Microbiota from Mouse Model to Clinical Patients and the Role of NF-κB Pathway in Polycystic Ovary Syndrome.

Kong F, Huang P, Chen J, Ma Y Reprod Sci. 2024; 31(11):3323-3333.

PMID: 38653859 DOI: 10.1007/s43032-024-01562-3.


Alterations in gut and genital microbiota associated with gynecological diseases: a systematic review and meta-analysis.

Zhou Z, Feng Y, Xie L, Ma S, Cai Z, Ma Y Reprod Biol Endocrinol. 2024; 22(1):13.

PMID: 38238814 PMC: 10795389. DOI: 10.1186/s12958-024-01184-z.


The association between gut microbiome and PCOS: evidence from meta-analysis and two-sample mendelian randomization.

Min Q, Geng H, Gao Q, Xu M Front Microbiol. 2023; 14:1203902.

PMID: 37555058 PMC: 10405626. DOI: 10.3389/fmicb.2023.1203902.


References
1.
Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

2.
Ferriman D, GALLWEY J . Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961; 21:1440-7. DOI: 10.1210/jcem-21-11-1440. View

3.
Repaci A, Gambineri A, Pasquali R . The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2010; 335(1):30-41. DOI: 10.1016/j.mce.2010.08.002. View

4.
Fawley J, Gourlay D . Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res. 2016; 202(1):225-34. PMC: 4834149. DOI: 10.1016/j.jss.2015.12.008. View

5.
Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y . Association between Polycystic Ovary Syndrome and Gut Microbiota. PLoS One. 2016; 11(4):e0153196. PMC: 4836746. DOI: 10.1371/journal.pone.0153196. View